We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/12/2019 15:28 | BeyondAir are more than likely just trying to get the deal improved, the choice is clear for CIR - litigation and all the costs involved, or simply improve the terms to BeyondAir........whi | pro_s2009 | |
20/12/2019 00:17 | Yes, its quite reassuring that someone of the calibre of Ian Johnson is happy to accept those terms. I was assuming the share price will be above 60p by late 2020 and so that will fall in well with those options. Trading update in January hopefully will set the ball rolling....... | pro_s2009 | |
20/12/2019 00:15 | I'm still baffled, how do you bank 10 million dollars , then raise 10 million dollars. Then say your the harmed party. Big respect if Beyond can get away with that. | bjfanc | |
19/12/2019 14:51 | Well Half that would do for me 31p | basem1 | |
19/12/2019 14:33 | a 3yr wait for 60p zzzzzzzzzzzzzzzzzzzz | purple11 | |
19/12/2019 13:17 | Interesting to see where it ends the day. If this is an attempt to negotiate/strong arm then it’s very aggressive. I think we can be assured by the fact that AZN are a 19% shareholder and as such I expect we will have access to some pretty mean legal counsel! | 74tom | |
19/12/2019 12:23 | House broker Peel Hunt estimated that "even in a worst-case scenario" removing BeyondAir's contribution from its sales forecasts without any cost offset, "Circassia still turns EBITDA positive in 2020, and maintains a positive cash balance across our forecast period" | pro_s2009 | |
19/12/2019 10:07 | As you say its tough titty. Business does not work that way, always a price to pay. | m5 | |
19/12/2019 09:45 | you can dress it up how you like but its just bad news | purple11 | |
19/12/2019 08:56 | The finncap note covers it. Page 6. Product launch was expected Q3 (or Q4) 2020 provide FDA approval was given in Q1 2020. So there is no immediate impact. | pro_s2009 | |
19/12/2019 08:52 | how does that affect CIR though as these litigation matters tend to be prolonged drawn out affairs, in terms of their product sales and how dependent are they on this agreement ? | pre |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions